Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

An in vitro model of granuloma-like cell aggregates substantiates early host immune responses against Mycobacterium massiliense infection.

Je S, Quan H, Na Y, Cho SN, Kim BJ, Seok SH.

Biol Open. 2016 Aug 15;5(8):1118-27. doi: 10.1242/bio.019315.

2.

Deletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulent.

Halloum I, Carrère-Kremer S, Blaise M, Viljoen A, Bernut A, Le Moigne V, Vilchèze C, Guérardel Y, Lutfalla G, Herrmann JL, Jacobs WR Jr, Kremer L.

Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):E4228-37. doi: 10.1073/pnas.1605477113. Epub 2016 Jul 6.

PMID:
27385830
3.

PE11, a PE/PPE family protein of Mycobacterium tuberculosis is involved in cell wall remodeling and virulence.

Singh P, Rao RN, Reddy JR, Prasad RB, Kotturu SK, Ghosh S, Mukhopadhyay S.

Sci Rep. 2016 Feb 23;6:21624. doi: 10.1038/srep21624.

4.

High-throughput transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium abscessus Smooth and Rough variants.

Aulicino A, Dinan AM, Miranda-CasoLuengo AA, Browne JA, Rue-Albrecht K, MacHugh DE, Loftus BJ.

BMC Genomics. 2015 Dec 9;16:1046. doi: 10.1186/s12864-015-2246-1.

5.

Clonal Diversification and Changes in Lipid Traits and Colony Morphology in Mycobacterium abscessus Clinical Isolates.

Park IK, Hsu AP, Tettelin H, Shallom SJ, Drake SK, Ding L, Wu UI, Adamo N, Prevots DR, Olivier KN, Holland SM, Sampaio EP, Zelazny AM.

J Clin Microbiol. 2015 Nov;53(11):3438-47. doi: 10.1128/JCM.02015-15. Epub 2015 Aug 19.

6.

Subinhibitory Doses of Aminoglycoside Antibiotics Induce Changes in the Phenotype of Mycobacterium abscessus.

Tsai SH, Lai HC, Hu ST.

Antimicrob Agents Chemother. 2015 Oct;59(10):6161-9. doi: 10.1128/AAC.01132-15. Epub 2015 Jul 20.

7.

Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipids.

Honda JR, Hess T, Malcolm KC, Ovrutsky AR, Bai X, Irani VR, Dobos KM, Chan ED, Flores SC.

PLoS One. 2015 May 18;10(5):e0126994. doi: 10.1371/journal.pone.0126994. eCollection 2015.

8.

Glycopeptidolipid of Mycobacterium smegmatis J15cs Affects Morphology and Survival in Host Cells.

Fujiwara N, Ohara N, Ogawa M, Maeda S, Naka T, Taniguchi H, Yamamoto S, Ayata M.

PLoS One. 2015 May 13;10(5):e0126813. doi: 10.1371/journal.pone.0126813. eCollection 2015.

9.

Mycobacterium abscessus morphotype comparison in a murine model.

Caverly LJ, Caceres SM, Fratelli C, Happoldt C, Kidwell KM, Malcolm KC, Nick JA, Nichols DP.

PLoS One. 2015 Feb 12;10(2):e0117657. doi: 10.1371/journal.pone.0117657. eCollection 2015.

10.

Essential engagement of Toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus.

Kim JS, Kang MJ, Kim WS, Han SJ, Kim HM, Kim HW, Kwon KW, Kim SJ, Cha SB, Eum SY, Koh WJ, Cho SN, Park JH, Shin SJ.

Infect Immun. 2015 Apr;83(4):1556-67. doi: 10.1128/IAI.02853-14. Epub 2015 Feb 2.

11.

Characterization of Proinflammatory Responses and Innate Signaling Activation in Macrophages Infected with Mycobacterium scrofulaceum.

Kim KH, Kim TS, Lee JG, Park JK, Yang M, Kim JM, Jo EK, Yuk JM.

Immune Netw. 2014 Dec;14(6):307-20. doi: 10.4110/in.2014.14.6.307. Epub 2014 Dec 22.

12.

Vertebral Osteomyelitis Caused by Mycobacterium abscessus Surgically Treated Using Antibacterial Iodine-Supported Instrumentation.

Kato S, Murakami H, Demura S, Yoshioka K, Hayashi H, Yokogawa N, Fang X, Tsuchiya H.

Case Rep Orthop. 2014;2014:197061. doi: 10.1155/2014/197061. Epub 2014 Dec 2.

13.

Host response to nontuberculous mycobacterial infections of current clinical importance.

Orme IM, Ordway DJ.

Infect Immun. 2014 Sep;82(9):3516-22. doi: 10.1128/IAI.01606-13. Epub 2014 Jun 9.

14.

In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system.

Bernut A, Le Moigne V, Lesne T, Lutfalla G, Herrmann JL, Kremer L.

Antimicrob Agents Chemother. 2014 Jul;58(7):4054-63. doi: 10.1128/AAC.00142-14. Epub 2014 May 5.

15.

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.

Qvist T, Pressler T, Høiby N, Katzenstein TL.

Respir Res. 2014 Apr 11;15:41. doi: 10.1186/1465-9921-15-41.

16.

Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation.

Bernut A, Herrmann JL, Kissa K, Dubremetz JF, Gaillard JL, Lutfalla G, Kremer L.

Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):E943-52. doi: 10.1073/pnas.1321390111. Epub 2014 Feb 24.

17.

Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential.

Choo SW, Wee WY, Ngeow YF, Mitchell W, Tan JL, Wong GJ, Zhao Y, Xiao J.

Sci Rep. 2014 Feb 11;4:4061. doi: 10.1038/srep04061.

18.

Rough colony morphology of Mycobacterium massiliense Type II genotype is due to the deletion of glycopeptidolipid locus within its genome.

Kim BJ, Kim BR, Lee SY, Kook YH, Kim BJ.

BMC Genomics. 2013 Dec 17;14:890. doi: 10.1186/1471-2164-14-890.

19.

Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens.

Rüger K, Hampel A, Billig S, Rücker N, Suerbaum S, Bange FC.

J Clin Microbiol. 2014 Jan;52(1):244-50. doi: 10.1128/JCM.01249-13. Epub 2013 Nov 6.

20.

Phylogenomics of Brazilian epidemic isolates of Mycobacterium abscessus subsp. bolletii reveals relationships of global outbreak strains.

Davidson RM, Hasan NA, de Moura VC, Duarte RS, Jackson M, Strong M.

Infect Genet Evol. 2013 Dec;20:292-7. doi: 10.1016/j.meegid.2013.09.012. Epub 2013 Sep 18.

Items per page

Supplemental Content

Write to the Help Desk